The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $61.90

Today's change+0.60 +0.98%
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $61.90

Today's change+0.60 +0.98%
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.

Quest Diagnostics Inc up (U.S.)$0.60

Quest Diagnostics Inc closed up Friday by (U.S.)$0.60 or 0.98% to (U.S.)$61.90. Over the last five days, shares have lost 0.24% and sit 3.76% above their 52-week low. This security has underperformed the S&P 500 by 2.90% during the last year.

Key company metrics

  • Open(U.S.) $61.75
  • Previous close(U.S.) $61.30
  • High(U.S.) $62.34
  • Low(U.S.) $61.55
  • Bid / Ask(U.S.) $59.06 / (U.S.) $64.82
  • YTD % change-12.99%
  • Volume739,455
  • Average volume (10-day)1,270,826
  • Average volume (1-month)1,148,056
  • Average volume (3-month)1,162,318
  • 52-week range(U.S.) $59.66 to (U.S.) $89.00
  • Beta0.67
  • Trailing P/E12.69×
  • P/E 1 year forward12.12×
  • Forward PEG1.34×
  • Indicated annual dividend(U.S.) $1.60
  • Dividend yield2.58%
  • Trailing EPS(U.S.) $4.88
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.05%

Based on its net profit margin of 10.05%, Quest Diagnostics Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue1,8491,8801,9251,839
Total other revenue--------
Total revenue1,8491,8801,9251,839
Gross profit711730747689
Total cost of revenue1,1381,1501,1781,150
Total operating expense1,6101,2491,6241,611
Selling / general / administrative419399427417
Research & development--------
Depreciation / amortization20202021
Interest expense (income), net operating--------
Unusual expense (income)22-319615
Other operating expenses, total11-1-78
Operating income239631301228
Interest income (expense), net non-operating---35-37-45
Gain (loss) on sale of assets--------
Other--------
Income before tax214593207112
Income after tax20035412970
Income tax, total142397842
Net income18834211861
Total adjustments to net income---2-10
Net income before extra. items18834211861
Minority interest-12-12-11-9
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items18834011761
Inc. avail. to common incl. extra. items18834011761
Diluted net income18834011761
Dilution adjustment0--0--
Diluted weighted average shares144145145146
Diluted EPS excluding extraordinary itemsvalue per share1.312.340.810.42
Dividends per sharevalue per share0.380.380.380.33
Diluted normalized EPSvalue per share1.451.030.840.48